drugset / Trial / NCT04223895
A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics and Safety/Tolerability of CKD-386
Timeline
- Start
- 2020-02-01
- Primary completion
- 2020-03-04
- Completion
- 2020-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-386 | Unknown | — | Oral |
| Background | D012 | Unknown | — | Oral |
| Background | D326 | Unknown | — | Oral |
| Background | D337 | Unknown | — | Oral |